학술논문
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial
Document Type
Article
Author
Napolitano, S.; Ciardiello, D.; De Falco, V.; Martini, G.; Martinelli, E.; Della Corte, C.M.; Esposito, L.; Famiglietti, V.; Di Liello, A.; Del Tufo, S.; De Vita, F.; Altucci, L.; Marrone, F.; Ciardiello, F.; Troiani, T.; Zampino, M.G.; Fazio, N.; Avallone, A.; Cardone, C.; De Stefano, A.; Montesarchio, V.; Di Maio, M.
Source
In: International Journal of Cancer . (International Journal of Cancer, 15 October 2023, 153(8):1520-1528)
Subject
Language
English
ISSN
10970215
00207136
00207136